[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biological Drugs Market Size, Status and Forecast 2022

August 2017 | 99 pages | ID: G6592A9B70FEN
QYResearch

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Biological Drugs market, analyzes and researches the Biological Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
  • Roche
  • Amgen
  • Novo Nordisk
  • Abbott Laboratories
  • Pfizer
  • Novartis
  • Eli Lilly
  • Bristol-Myers Squibb
  • Biogen
  • Baxter
Market segment by Regions/Countries, this report covers
  • United States
  • EU
  • Japan
  • China
  • India
  • Southeast Asia
Market segment by Type, Biological Drugs can be split into
  • Gardasil
  • Prenvar 13
  • Fluzone
  • Cervarix
  • Varivax
Market segment by Application, Biological Drugs can be split into
  • Auto-Immune Diseases
  • Blood Diseases
  • Cancer-Related Conditions
  • Diabetes
  • Cardiovascular Diseases
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Biological Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF BIOLOGICAL DRUGS

1.1 Biological Drugs Market Overview
  1.1.1 Biological Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Biological Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Biological Drugs Market by Type
  1.3.1 Gardasil
  1.3.2 Prenvar
  1.3.3 Fluzone
  1.3.4 Cervarix
  1.3.5 Varivax
1.4 Biological Drugs Market by End Users/Application
  1.4.1 Auto-Immune Diseases
  1.4.2 Blood Diseases
  1.4.3 Cancer-Related Conditions
  1.4.4 Diabetes
  1.4.5 Cardiovascular Diseases

2 GLOBAL BIOLOGICAL DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Biological Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Roche
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Biological Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Amgen
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Biological Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Novo Nordisk
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Biological Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Abbott Laboratories
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Biological Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Pfizer
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Biological Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Novartis
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Biological Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Eli Lilly
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Biological Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Bristol-Myers Squibb
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Biological Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Biogen
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Biological Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Baxter
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Biological Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments

4 GLOBAL BIOLOGICAL DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Biological Drugs Market Size by Type (2012-2017)
4.2 Global Biological Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Biological Drugs in Future
4.4 Top Consumer/End Users of Biological Drugs

5 UNITED STATES BIOLOGICAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Biological Drugs Market Size (2012-2017)
5.2 United States Biological Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU BIOLOGICAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Biological Drugs Market Size (2012-2017)
6.2 EU Biological Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN BIOLOGICAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Biological Drugs Market Size (2012-2017)
7.2 Japan Biological Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA BIOLOGICAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Biological Drugs Market Size (2012-2017)
8.2 China Biological Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA BIOLOGICAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Biological Drugs Market Size (2012-2017)
9.2 India Biological Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA BIOLOGICAL DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Biological Drugs Market Size (2012-2017)
10.2 Southeast Asia Biological Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Biological Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Biological Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Biological Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Biological Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Biological Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Biological Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Biological Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Biological Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Biological Drugs Market Size by Application (2017-2022)

12 BIOLOGICAL DRUGS MARKET DYNAMICS

12.1 Biological Drugs Market Opportunities
12.2 Biological Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Biological Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Biological Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Biological Drugs Product Scope
Figure Global Biological Drugs Market Size (Million USD) (2012-2017)
Table Global Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Biological Drugs Market Share by Regions in 2016
Figure United States Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Biological Drugs Market Share by Type in 2016
Figure Gardasil Market Size (Million USD) and Growth Rate (2012-2017)
Figure Prenvar 13 Market Size (Million USD) and Growth Rate (2012-2017)
Figure Fluzone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Cervarix Market Size (Million USD) and Growth Rate (2012-2017)
Figure Varivax Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Biological Drugs Market Share by Application in 2016
Table Key Downstream Customer in Auto-Immune Diseases
Figure Biological Drugs Market Size (Million USD) and Growth Rate in Auto-Immune Diseases (2012-2017)
Table Key Downstream Customer in Blood Diseases
Figure Biological Drugs Market Size (Million USD) and Growth Rate in Blood Diseases (2012-2017)
Table Key Downstream Customer in Cancer-Related Conditions
Figure Biological Drugs Market Size (Million USD) and Growth Rate in Cancer-Related Conditions (2012-2017)
Table Key Downstream Customer in Diabetes
Figure Biological Drugs Market Size (Million USD) and Growth Rate in Diabetes (2012-2017)
Table Key Downstream Customer in Cardiovascular Diseases
Figure Biological Drugs Market Size (Million USD) and Growth Rate in Cardiovascular Diseases (2012-2017)
Table Biological Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Biological Drugs Market Size Share by Players in 2016
Figure Biological Drugs Market Size Share by Players in 2017
Table Roche Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Roche (2012-2017)
Figure Roche Biological Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Biological Drugs Business Revenue Market Share in 2016
Table Novo Nordisk Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Novo Nordisk (2012-2017)
Figure Novo Nordisk Biological Drugs Business Revenue Market Share in 2016
Table Abbott Laboratories Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories Biological Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Biological Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Biological Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Biological Drugs Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Biological Drugs Business Revenue Market Share in 2016
Table Biogen Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Biogen (2012-2017)
Figure Biogen Biological Drugs Business Revenue Market Share in 2016
Table Baxter Basic Information List
Table Biological Drugs Business Revenue (Million USD) of Baxter (2012-2017)
Figure Baxter Biological Drugs Business Revenue Market Share in 2016
Table Global Biological Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Biological Drugs Market Size Share by Type in 2012
Figure Global Biological Drugs Market Size Share by Type in 2013
Figure Global Biological Drugs Market Size Share by Type in 2014
Figure Global Biological Drugs Market Size Share by Type in 2015
Figure Global Biological Drugs Market Size Share by Type in 2016
Figure Global Biological Drugs Market Size Share by Type in 2017
Table Global Biological Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Biological Drugs Market Size (Million USD) by Application in 2012
Figure Global Biological Drugs Market Size (Million USD) by Application in 2013
Figure Global Biological Drugs Market Size (Million USD) by Application in 2014
Figure Global Biological Drugs Market Size (Million USD) by Application in 2015
Figure Global Biological Drugs Market Size (Million USD) by Application in 2016
Figure Global Biological Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Biological Drugs
Figure United States Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Biological Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Biological Drugs Market Size Share by Players in 2016
Figure United States Biological Drugs Market Size Share by Players in 2017
Figure EU Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Biological Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Biological Drugs Market Size Share by Players in 2016
Figure EU Biological Drugs Market Size Share by Players in 2017
Figure Japan Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Biological Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Biological Drugs Market Size Share by Players in 2016
Figure Japan Biological Drugs Market Size Share by Players in 2017
Figure China Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Biological Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Biological Drugs Market Size Share by Players in 2016
Figure China Biological Drugs Market Size Share by Players in 2017
Figure India Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Biological Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Biological Drugs Market Size Share by Players in 2016
Figure India Biological Drugs Market Size Share by Players in 2017
Figure Southeast Asia Biological Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Biological Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Biological Drugs Market Size Share by Players in 2016
Figure Southeast Asia Biological Drugs Market Size Share by Players in 2017
Figure Global Biological Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Biological Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Biological Drugs Market Size Share by Regions in 2017
Figure Global Biological Drugs Market Size Share by Regions in 2022
Figure United States Biological Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Biological Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Biological Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Biological Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Biological Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Biological Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Biological Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Biological Drugs Market Size Share by Type in 2017
Figure Global Biological Drugs Market Size Share by Type in 2022
Table Global Biological Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Biological Drugs Market Size (Million USD) by Application in 2017
Figure Global Biological Drugs Market Size (Million USD) by Application in 2022


More Publications